Monitor for actual sales by the selling stockholders, particularly Samsara BioCapital which could sell up to 1.5M shares. The low warrant exercise price suggests warrants will likely be exercised, potentially increasing shares outstanding. This registration enables liquidity for early investors but creates overhang pressure on the stock.
Price Chart
Executive Summary
Kalaris Therapeutics filed an S-3 shelf registration to allow certain selling stockholders to resell up to 5,000,000 shares of common stock, including 4,200,000 existing shares and 800,000 shares issuable upon exercise of pre-funded warrants. The company will not receive proceeds from the resale, but may receive $80 from warrant exercises. This is a routine registration to fulfill contractual obligations from a prior private placement.
Key Financial Metrics
Key Facts
- S-3 shelf registration filed for resale of 5,000,000 shares by selling stockholders
- Shares consist of 4,200,000 existing shares and 800,000 shares from pre-funded warrants
- Company will not receive proceeds from share sales, but may receive $80 from warrant exercises
- Registration fulfills contractual obligations from December 2025 private placement
- Selling stockholders include Samsara BioCapital, RTW Investments, and others
- Market cap is $133M with recent insider selling of $13K
Financial Impact
Potential dilution of up to 21.8% of current shares outstanding if all shares are sold and warrants exercised
Risk Factors
- Potential stock price pressure from selling stockholder sales
- Dilution if pre-funded warrants are exercised
- Concentration risk with principal stockholder Samsara BioCapital
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-142151 |
| Document: d143090dexfilingfees.htm | 0001193125-26-142151 |
| Document: d143090dex51.htm | 0001193125-26-142151 |
| Document: d143090dex231.htm | 0001193125-26-142151 |
| Document: 0001193125-26-142151-index-headers.html | 0001193125-26-142151 |
| Document: 0001193125-26-142151-index.html | 0001193125-26-142151 |
| Document: 0001193125-26-142151.txt | 0001193125-26-142151 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13G | $1.80 | awaiting T+60 | — | $1.80 (−0.00%) |
Aug 11, 2026 11w ago | 8-K | $3.97 | awaiting T+60 | — | $1.80 (−54.66%) |
Aug 11, 2026 11w ago | Press Release | $3.97 | awaiting T+60 | — | $1.80 (−54.66%) |
Aug 3, 2026 12w ago | 3 | $4.32 | awaiting T+60 | — | $1.80 (−58.33%) |
Jul 20, 2026 14w ago | 8-K | $4.00 $2.23 | ▼ −44.25% | ▼ −49.09% | $1.80 (−55.00%) |
Jul 17, 2026 14w ago | 8-K | $4.38 $2.26 | ▼ −48.40% | ▼ −53.09% | $1.80 (−58.90%) |
Jul 17, 2026 14w ago | Press Release | $4.38 $2.26 | ▼ −48.40% | ▼ −53.09% | $1.80 (−58.90%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.36 $3.90 | ▼ −10.55% | ▼ −14.95% | $1.80 (−58.72%) |
May 12, 2026 24w ago | 8-K | $4.79 $4.19 | ▼ −12.53% | ▼ −16.91% | $1.80 (−62.42%) |
May 12, 2026 24w ago | Press Release | $4.79 $4.19 | ▼ −12.53% | ▼ −16.91% | $1.80 (−62.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers